Apomorphine-induced behavioural sensitization in rats: Individual differences, role of dopamine and NMDA receptors

European Neuropsychopharmacology

Volumn 9, Issue 6, 1999, Pages 507-514

  Võikar, Vootele ^a   Soosaar, Andres ^a   Volke, Vallo ^a   Kõks, Sulev ^a   Bourin, Michel ^b   Männistö, Pekka T ^c   Vasar, Eero ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITÉ DE NANTES   (France)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Apomorphine; Behavioural sensitization; Dopamine D1 receptors; Dopamine D2 receptors; Locomotor activity; NMDA receptors; Stereotyped behaviour

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE DERIVATIVE; APOMORPHINE; CLOZAPINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RACLOPRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GNAWING; LICKING; MUSCULOSKELETAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; SNIFFING; SOCIAL PSYCHOLOGY; STEREOTYPY;

AMPHETAMINE; ANIMALS; APOMORPHINE; DIZOCILPINE MALEATE; DOPAMINE AGENTS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; RECEPTORS, N-METHYL-D-ASPARTATE; STEREOTYPED BEHAVIOR;

EID: 0343920667     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(99)00038-3     Document Type: Article

References (41)

1. Allikmets L., Vasar E. Sensitization of male rats to aggressive behavior. Zh. Vyssh. Nerv. Deiat. 32:1982;130-135. (In Russian).
2. Bowers M.B. Jr. The role of drugs in the production of schizophreniform psychoses and related disorders. Meltzer H.Y. Psychopharmacology: the Third Generation of Progress. 1987;819-823 Raven Press, New York.
3. 2 dopamine receptor classification and its functional implications. Synapse. 1:1987;347-388.
4. Costall B., Naylor R.J. The involvement of dopaminergic systems with the stereotyped behavior patterns induced by methylphenidate. J. Pharm. Pharmacol. 26:1974;30-33.
5. Creese I., Hamblin M.W., Leff S.E., Sibley D.R. CNS dopamine receptors. Iversen L.L., Iversen S.D., Snyder S.H. Handbook of Psychopharmacology: Biochemical Studies of CNS Receptors. 1983;81-138 Plenum Press, New York.
6. Connell P.H. The use and abuse of amphetamines. Practioner. 200:1968;234-243.
7. Druhan J.P., Jakob A., Stewart J. The development of behavioral sensitization to apomorphine is blocked by MK-801. Eur. J. Pharmacol. 243:1993;73-77.
8. Ellison G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res. Rev. 20:1995;250-267.
9. Essman W.D., Luedtke R.R., McGonigle P., Lucki I. Variations in the behavioral responses to apomorphine in different strains of rats. Behav. Pharmacol. 6:1995;4-15.
10. Fawcett J., Busch K.A. Stimulants in psychiatry. Schatzberg A.F., Nemeroff C.B. The American Psychiatric Press. Textbook of Psychopharmacology. 1995;417-435 American Psychiatric Press, Washington, DC.
11. Fields J.Z., Drucker G.E., Wichlinski L., Gordon J.H. Neurochemical basis for the absence of overt 'stereotyped' behaviors in rats with up-regulated striatal D2 dopamine receptors. Clin. Neuropharmacol. 14:1991;199-208.
12. Fischman M.W. Cocaine and the amphetamines. Meltzer H.Y. Psychopharmacology: the Third Generation of Progress. 1987;1543-1553 Raven Press, New York.
13. 2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 546:1991;40-46.
14. Hooks M.S., Jones G.H., Smith A.D., Neill D.B., Justice J.B. Jr. Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse. 9:1991;121-128.
15. Hooks M.S., Jones D.N., Holtzmann S.G., Juncos J.L., Kalivas P.W., Justice J.B. Jr. Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole. Psychopharmacology. 116:1994;217-225.
16. Kalivas P.W., Duffy P., DuMars L.A., Skinner C. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J. Pharmacol. Exp. Ther. 245:1988;485-492.
17. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. 16:1991;223-244.
18. Karler R., Calder L.D., Chaudhry I.A., Turkanis S.A. Blockade of 'reverse tolerance' to cocaine and amphetamine. Life Sci. 45:1989;599-606.
19. Karler R., Chaudhry I.A., Calder L.D., Turkanis S.A. Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res. 537:1990;76-82.
20. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. Subanesthetic doses of ketamine stimulate the psychosis in schizophrenia. Neuropsychopharmacology. 13:1995;9-19.
21. Lang A., Vasar E., Soosaar A., Harro J. The involvement of sigma and phencyclidine receptors in the action of antipsychotic drugs. Pharmacol. Toxicol. 70:1992;132-138.
22. Lang A., Soosaar A., Kõks S., Volke V., Bourin M., Bradwejn J., Vasar E. Pharmacological comparison of antipsychotic drugs and sigma antagonists in rodents. Pharmacol. Toxicol. 75:1994;222-227.
23. Lang A., Harro J., Soosaar A., Kõks S., Volke V., Oreland L., Bourin M., Vasar F., Bradwejn J., Männistö P.T. Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behavior in rats. Naunyn Schmiedeberg's Arch. Pharmacol. 351:1995;363-370.
24. Losonczy M.F., Davidson M., Davis K.A. The dopamine hypothesis of schizophrenia. Meltzer H.Y. Psychopharmacology: the Third Generation of Progress. 1987;715-726 Raven Press, New York.
25. 2 dopamine antagonists on the development of behavioral sensitization to apomorphine. Psychopharmacology. 105:1991;501-507.
26. Mele A., Thomas D.N., Pert A. Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity. Neuroscience. 82:1998;43-58.
27. Meyer R.E. Biology of psychoactive substance dependence disorders: opiates, cocaine and ethanol. Schatzberg A.F., Nemeroff C.B. The American Psychiatric Press. Textbook of Psychopharmacology. 1995;537-556 American Psychiatric Press, Washington, DC.
28. Peris J., Zahniser N.R. Persistent augmented dopamine release after acute cocaine requires dopamine receptor activation. Pharmacol. Biochem. Behav. 32:1989;71-76.
29. Porreca F., Conan A., Tallarida R.J. Differentiation of apomorphine from bromocriptine, piribedil and TRH by chronic administration in rats. Psychopharmacology. 76:1982;70-74.
30. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
31. Rowlett J.K., Mattingly B.A. Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats. Neuropharmacology. 30:1991;191-197.
32. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1:1987;133-152.
33. Seeman P., Ulpian C. Dopamine D1 and D2 receptor selectivities of agonists and antagonists. Adv. Exp. Med. Biol. 235:1988;55-63.
34. Seeman P., Van Tol H.H.M. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:1994;264-270.
35. Segal D.S., Kuczenski R. Individual differences in responsiveness to single and repeated amphetamine administration: behavioral characteristics and neurochemical correlates. J. Pharmacol. Exp. Ther. 242:1987;917-926.
36. Sokoloff P., Schwartz J.-C. Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16:1995;270-275.
37. Tallarida R.J., Murray R.B. Manual of Pharmacological Calculations With Computer Programs. 1986;Springer-Verlag, New York.
38. Ujike H., Onoune T., Akiyama K., Hamamura T., Otsuki S. Effects of selective D-l and D-2 dopamine antagonists on the development of methamphetamine-induced behavioral sensitization. Psychopharmacology. 98:1989;89-92.
39. Wolf M.E., Khansa M.R. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562:1991;164-168.
40. Wolf M.E., Dahlin S.L., Hu X.-T., Xue C.-J., White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience. 69:1995;417-439.
41. Zetterström T., Sharp T., Marsden C.A., Ungerstedt U. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after D-amphetamine. J. Neurochem. 41:1983;1769-1773.